S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.10 (+0.14%) NASDAQ 26,517.93 ▲ 496.23 (+1.91%) US Markets Closed â€ĸ 09:29 PM ET

PYPD

PolyPid Ltd.

Price Chart
Latest Quote

$4.74

+0.18 (+3.95%)
Current Price
Previous Close $4.56
Open $4.56
Day High $4.83
Day Low $4.56
Volume 101,277
Fetched: 2026-06-22T01:29:36
Stock Information
Shares Outstanding 19.17M
Total Debt $2.34M
Cash Equivalents $10.91M
Net Income $-33.63M
Sector Healthcare
Industry Biotechnology
Market Cap $90.89M
EPS (TTM) $-1.72
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$82.32M
Income$-33.63M
Book/sh$0.46
Cash/sh$0.57
Employees69
Financial Ratios
Quick Ratio1.55
Current Ratio1.78
Debt/Eq26.69
Returns & Margins
ROA-115.07%
ROE-758.61%
Ownership
Insider Ownership21.23%
Institutional Ownership34.85%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-3.78
P/B10.35
Analyst Data
Recommendationnone
Target Price$12.25
Technical Indicators
SMA20$4.72
SMA50$4.61
SMA200$4.14
RSI50.55
ATR0.2906
Shares Float10.91M
Short Float0.98%
Short Ratio1.29
Volatility1.43
Rel Volume0.74
Performance History
Week+3.72%
Month-0.42%
Quarter+8.47%
6 Months+20.00%
YTD+8.97%
Year+34.28%
3 Years-62.29%
5 Years-98.30%
10 Years-99.17%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $4.74 101,300
2026-06-17 $4.56 24,300
2026-06-16 $4.66 58,200
2026-06-15 $4.66 33,800
2026-06-12 $4.62 61,900
2026-06-11 $4.57 103,100
2026-06-10 $4.51 52,100
2026-06-09 $4.57 69,100
2026-06-08 $4.62 68,600
2026-06-05 $4.50 215,100
2026-06-04 $4.83 170,300
2026-06-03 $4.72 202,800
2026-06-02 $4.87 197,200
2026-06-01 $5.07 370,700
2026-05-29 $4.72 55,300
2026-05-28 $4.76 157,100
2026-05-27 $4.77 238,700
2026-05-26 $4.84 149,000
2026-05-22 $5.02 198,500
2026-05-21 $4.83 223,800
2026-05-20 $4.85 214,600
2026-05-19 $4.76 108,100
About PolyPid Ltd.

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. The company is also developing OncoPLEX, which is in preclinical stage for the treatment of intra-tumoral cancer. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $874,000 $1,510,000 $1,618,000 $540,000
Total Expenses $32,967,000 $28,029,000 $22,867,000 $38,888,000
Other Income Expense $-838,000 $113,000 $234,000 $532,000
Net Non Operating Interest Income Expense $-359,000 $-1,064,000 $-1,163,000 $-540,000
Total Other Finance Cost $2,000 $-4,000 $93,000 $316,000
Interest Expense Non Operating $874,000 $1,510,000 $1,618,000 $540,000
Operating Expense $32,967,000 $28,029,000 $22,867,000 $38,888,000
Selling And Marketing Expense $1,977,000 $945,000 $1,196,000 $2,888,000
General And Administrative Expense $7,183,000 $4,273,000 $5,523,000 $8,010,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Net Interest Income $-359,000 $-1,064,000 $-1,163,000 $-540,000
Interest Income $517,000 $442,000 $548,000 $267,000
Normalized Income $-33,331,000 $-29,109,010 $-24,045,180 $-39,557,000
Net Income From Continuing And Discontinued Operation $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Total Operating Income As Reported $-32,967,000 $-28,029,000 $-22,867,000 $-38,888,000
Net Income Common Stockholders $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Net Income $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Net Income Including Noncontrolling Interests $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Net Income Continuous Operations $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Pretax Income $-34,164,000 $-28,980,000 $-23,796,000 $-39,428,000
Special Income Charges $-512,000 $0 $0 -
Interest Income Non Operating $517,000 $442,000 $548,000 $267,000
Operating Income $-32,967,000 $-28,029,000 $-22,867,000 $-38,888,000
Per Share
Diluted EPS $-2.09 $-4.91 $-16.99 $-60.90
Basic EPS $-2.09 $-4.91 $-16.99 $-60.90
Other
Tax Effect Of Unusual Items $0 $25,990 $53,820 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-30,994,000 $-25,961,000 $-20,590,000 $-37,167,000
Total Unusual Items $-838,000 $113,000 $234,000 $532,000
Total Unusual Items Excluding Goodwill $-838,000 $113,000 $234,000 $532,000
Reconciled Depreciation $1,458,000 $1,622,000 $1,822,000 $1,721,000
EBITDA (Bullshit earnings) $-31,832,000 $-25,848,000 $-20,356,000 $-37,167,000
EBIT $-33,290,000 $-27,470,000 $-22,178,000 $-38,888,000
Diluted Average Shares $16,351,890 $5,912,890 $1,421,308 $647,556
Basic Average Shares $16,351,890 $5,912,890 $1,404,368 $647,556
Diluted NI Availto Com Stockholders $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Tax Provision $5,000 $42,000 $69,000 $129,000
Other Special Charges $512,000 - - -
Gain On Sale Of Security $-326,000 $113,000 $234,000 $532,000
Research And Development $23,807,000 $22,811,000 $16,148,000 $27,990,000
Selling General And Administration $9,160,000 $5,218,000 $6,719,000 $10,898,000
Other Gand A $7,183,000 $4,273,000 $5,523,000 $8,010,000
Otherunder Preferred Stock Dividend - - - $0
Fetched: 2026-06-18
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $10,973,000 $7,684,000 $-2,096,000 $5,829,000
Total Assets $22,307,000 $25,220,000 $15,372,000 $25,971,000
Total Non Current Assets $7,080,000 $8,647,000 $9,305,000 $11,777,000
Other Non Current Assets $311,000 $277,000 $87,000 $99,000
Current Assets $15,227,000 $16,573,000 $6,067,000 $14,194,000
Other Current Assets $632,000 $434,000 $106,000 $537,000
Restricted Cash $193,000 $168,000 $300,000 $511,000
Prepaid Assets $363,000 $330,000 $352,000 $552,000
Inventory $1,106,000 $0 - -
Cash Cash Equivalents And Short Term Investments $12,933,000 $15,641,000 $5,309,000 $12,594,000
Cash And Cash Equivalents $6,402,000 $15,641,000 $5,309,000 $8,552,000
Receivables - - - $298,000
Other Receivables - - - $298,000
Non Current Prepaid Assets - - - -
Debt
Total Debt $2,796,000 $9,617,000 $11,779,000 $13,730,000
Long Term Debt And Capital Lease Obligation $647,000 $1,911,000 $7,236,000 $8,747,000
Current Debt And Capital Lease Obligation $2,149,000 $7,706,000 $4,543,000 $4,983,000
Current Debt $988,000 $6,787,000 $4,003,000 $4,024,000
Other Current Borrowings $988,000 $6,787,000 $4,003,000 $4,024,000
Long Term Debt - $634,000 $6,379,000 $7,574,000
Net Debt - - $5,073,000 $3,046,000
Liabilities
Total Liabilities Net Minority Interest $11,334,000 $17,536,000 $17,468,000 $20,142,000
Total Non Current Liabilities Net Minority Interest $3,595,000 $4,855,000 $10,182,000 $11,589,000
Other Non Current Liabilities $400,000 $396,000 $398,000 $294,000
Non Current Deferred Liabilities $2,548,000 $2,548,000 $2,548,000 $2,548,000
Current Liabilities $7,739,000 $12,681,000 $7,286,000 $8,553,000
Other Current Liabilities $8,000 $23,000 $18,000 $16,000
Payables And Accrued Expenses $5,582,000 $4,952,000 $2,725,000 $3,554,000
Payables $2,856,000 $2,409,000 $772,000 $1,141,000
Accounts Payable $2,856,000 $2,409,000 $772,000 $1,141,000
Current Deferred Liabilities - - - $0
Other Payable - - - $16,000
Equity
Common Stock Equity $10,973,000 $7,684,000 $-2,096,000 $5,829,000
Total Equity Gross Minority Interest $10,973,000 $7,684,000 $-2,096,000 $5,829,000
Stockholders Equity $10,973,000 $7,684,000 $-2,096,000 $5,829,000
Retained Earnings $-301,500,000 $-267,331,000 $-238,309,000 $-214,444,000
Other
Ordinary Shares Number $18,204,002 $10,190,904 $1,653,559 $661,727
Share Issued $18,204,002 $10,190,904 $1,653,559 $661,727
Tangible Book Value $10,973,000 $7,684,000 $-2,096,000 $5,829,000
Invested Capital $11,961,000 $15,105,000 $8,286,000 $17,427,000
Working Capital $7,488,000 $3,892,000 $-1,219,000 $5,641,000
Capital Lease Obligations $1,808,000 $2,196,000 $1,397,000 $2,132,000
Total Capitalization $10,973,000 $8,318,000 $4,283,000 $13,403,000
Additional Paid In Capital $312,473,000 $275,015,000 $236,213,000 $220,273,000
Capital Stock $0 $0 $0 $0
Common Stock $0 $0 $0 $0
Non Current Deferred Revenue $2,548,000 $2,548,000 $2,548,000 $2,548,000
Long Term Capital Lease Obligation $647,000 $1,277,000 $857,000 $1,173,000
Current Capital Lease Obligation $1,161,000 $919,000 $540,000 $959,000
Current Accrued Expenses $2,726,000 $2,543,000 $1,953,000 $2,413,000
Net PPE $6,769,000 $8,370,000 $9,218,000 $11,678,000
Accumulated Depreciation $-10,877,000 $-9,419,000 $-7,797,000 $-5,975,000
Gross PPE $17,646,000 $17,789,000 $17,015,000 $17,653,000
Leases $6,567,000 $6,524,000 $6,503,000 $6,503,000
Other Properties $10,116,000 $10,462,000 $9,719,000 $10,364,000
Machinery Furniture Equipment $963,000 $803,000 $793,000 $786,000
Properties $0 $0 $0 $0
Other Short Term Investments $6,531,000 $0 $0 $4,042,000
Treasury Shares Number - - $0 -
Current Deferred Revenue - - - $0
Fetched: 2026-06-18
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-28,089,000 $-22,039,000 $-17,432,000 $-36,084,000
Operating Activities
Operating Cash Flow $-27,879,000 $-21,963,000 $-17,236,000 $-34,317,000
Cash Flow From Continuing Operating Activities $-27,879,000 $-21,963,000 $-17,236,000 $-34,317,000
Operating Gains Losses $512,000 - $-201,000 -
Investing Activities
Capital Expenditure $-210,000 $-76,000 $-196,000 $-1,767,000
Investing Cash Flow $-6,704,000 $-330,000 $3,804,000 $16,575,000
Cash Flow From Continuing Investing Activities $-6,704,000 $-330,000 $3,804,000 $16,575,000
Financing Activities
Issuance Of Capital Stock $32,603,000 $35,863,000 $12,710,000 $5,011,000
Financing Cash Flow $25,369,000 $32,416,000 $9,976,000 $16,428,000
Cash Flow From Continuing Financing Activities $25,369,000 $32,416,000 $9,976,000 $16,428,000
Net Other Financing Charges $-859,000 $-125,000 $-125,000 -
Net Common Stock Issuance $32,603,000 $35,863,000 $12,710,000 $5,011,000
Common Stock Issuance $32,603,000 $35,863,000 $12,710,000 $5,011,000
Net Preferred Stock Issuance - - - -
Preferred Stock Issuance - - - -
Other
Repayment Of Debt $-6,376,000 $-3,322,000 $-2,618,000 $-402,000
Interest Paid Supplemental Data $557,000 $950,000 $1,038,000 $734,000
Income Tax Paid Supplemental Data $5,000 $3,000 $18,000 $8,000
End Cash Position $6,595,000 $15,809,000 $5,686,000 $9,142,000
Beginning Cash Position $15,809,000 $5,686,000 $9,142,000 $10,456,000
Changes In Cash $-9,214,000 $10,123,000 $-3,456,000 $-1,314,000
Proceeds From Stock Option Exercised $1,000 $0 $9,000 $108,000
Net Issuance Payments Of Debt $-6,376,000 $-3,322,000 $-2,618,000 $11,309,000
Net Long Term Debt Issuance $-6,376,000 $-3,322,000 $-2,618,000 $11,309,000
Long Term Debt Payments $-6,376,000 $-3,322,000 $-2,618,000 $-402,000
Net Investment Purchase And Sale $-6,494,000 $-254,000 $4,000,000 $18,342,000
Sale Of Investment $19,722,000 $21,099,000 $22,600,000 $25,342,000
Purchase Of Investment $-26,216,000 $-21,353,000 $-18,600,000 $-7,000,000
Net PPE Purchase And Sale $-210,000 $-76,000 $-196,000 $-1,767,000
Purchase Of PPE $-210,000 $-76,000 $-196,000 $-1,767,000
Change In Working Capital $359,000 $1,916,000 $-110,000 $-1,077,000
Change In Other Current Liabilities $-675,000 $-723,000 $-494,000 $2,132,000
Change In Other Current Assets $907,000 $824,000 $593,000 $-2,431,000
Change In Payables And Accrued Expense $352,000 $2,130,000 $-850,000 $-4,511,000
Change In Accrued Expense $172,000 $493,000 $-481,000 $-1,416,000
Change In Payable $180,000 $1,637,000 $-369,000 $-3,095,000
Change In Account Payable $180,000 $1,637,000 $-369,000 $-3,095,000
Change In Prepaid Assets $-225,000 $-315,000 $641,000 $1,185,000
Other Non Cash Items $-893,000 $697,000 $1,727,000 $289,000
Stock Based Compensation $4,854,000 $2,824,000 $3,391,000 $4,307,000
Depreciation Amortization Depletion $1,458,000 $1,622,000 $1,822,000 $1,721,000
Depreciation And Amortization $1,458,000 $1,622,000 $1,822,000 $1,721,000
Depreciation $1,458,000 $1,622,000 $1,822,000 $1,721,000
Net Income From Continuing Operations $-34,169,000 $-29,022,000 $-23,865,000 $-39,557,000
Issuance Of Debt - $0 $0 $11,711,000
Long Term Debt Issuance - $0 $0 $11,711,000
Gain Loss On Investment Securities - - $-201,000 -
Change In Other Working Capital - - - $2,548,000
Fetched: 2026-06-18